To establish the effect of BRCA1 on inflammasome activation in mammary cells, we analyzed IL‐1β secretion and caspase 1 activation in MCF10A cells with detectable inflammasome‐associated components, compared to several breast cancer cell lines (Figure S8, Supporting Information). Here, IL1B is linked to breast carcinoma.